Diagnosing von Willebrand disease: genetic analysis

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):678-682. doi: 10.1182/asheducation-2016.1.678.

Abstract

Investigation of a patient with possible von Willebrand disease (VWD) includes a range of phenotypic analyses. Often, this is sufficient to discern disease type, and this will suggest relevant treatment. However, for some patients, phenotypic analysis does not sufficiently explain the patient's disorder, and for this group, genetic analysis can aid diagnosis of disease type. Polymerase chain reaction and Sanger sequencing have been mainstays of genetic analysis for several years. More recently, next-generation sequencing has become available, with the advantage that several genes can be simultaneously analyzed where necessary, eg, for discrimination of possible type 2N VWD or mild hemophilia A. Additionally, several techniques can now identify deletions/duplications of an exon or more that result in VWD including multiplex ligation-dependent probe amplification and microarray analysis. Algorithms based on next-generation sequencing data can also identify missing or duplicated regions. These newer techniques enable causative von Willebrand factor defects to be identified in more patients than previously, aiding in a specific VWD diagnosis. Genetic analysis can also be helpful in the discrimination between type 2B and platelet-type VWD and in prenatal diagnosis for families with type 3.

Publication types

  • Review

MeSH terms

  • Base Sequence*
  • Hemophilia A / diagnosis
  • Hemophilia A / genetics
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Multiplex Polymerase Chain Reaction / methods*
  • Sequence Deletion*
  • von Willebrand Disease, Type 2* / diagnosis
  • von Willebrand Disease, Type 2* / genetics
  • von Willebrand Disease, Type 3* / diagnosis
  • von Willebrand Disease, Type 3* / genetics